{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:29:49Z","timestamp":1788406189860,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:00:00Z","timestamp":1614643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12325-020-01612-7","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:03:47Z","timestamp":1614701027000},"page":"2027-2037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Comparison of the Long-Acting GnRH Agonist Follicular Protocol with the GnRH Antagonist Protocol in Women Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Rui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"key":"1612_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s13224-015-0723-8","volume":"65","author":"GN Allahbadia","year":"2015","unstructured":"Allahbadia GN. The ideal stimulation protocol: is there one? J Obstet Gynaecol India. 2015;65:357\u201361.","journal-title":"J Obstet Gynaecol India"},{"key":"1612_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000362274","volume":"78","author":"L van den Wijngaard","year":"2014","unstructured":"van den Wijngaard L, van Wely M, Dancet EAF, et al. Patients\u2019 preferences for gonadotrophin-releasing hormone analogs in in vitro fertilization. Gynecol Obstet Investig. 2014;78:16\u201321.","journal-title":"Gynecol Obstet Investig"},{"key":"1612_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","volume":"58","author":"EG Hughes","year":"1992","unstructured":"Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 1992;58:888\u201396.","journal-title":"Fertil Steril"},{"key":"1612_CR4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S1701-2163(16)30206-7","volume":"25","author":"E Shalev","year":"2003","unstructured":"Shalev E, Leung PCK. Gonadotropin-releasing hormone and reproductive medicine. J Obstet Gynaecol Can. 2003;25:98\u2013113.","journal-title":"J Obstet Gynaecol Can"},{"key":"1612_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09513590.2018.1528221","volume":"35","author":"Y Geng","year":"2019","unstructured":"Geng Y, Xun Y, Hu S, Lai Q, Jin L. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation. Gynecol Endocrinol. 2019;35:309\u201313.","journal-title":"Gynecol Endocrinol"},{"key":"1612_CR6","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0015-0282(02)03373-3","volume":"78","author":"ES Surrey","year":"2002","unstructured":"Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78:699\u2013704.","journal-title":"Fertil Steril"},{"key":"1612_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.fertnstert.2014.03.030","volume":"102","author":"J Ren","year":"2014","unstructured":"Ren J, Sha A, Han D, Li P, Geng J, Ma C. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? Fertil Steril. 2014;102:75\u201381.","journal-title":"Fertil Steril"},{"key":"1612_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23:560\u201379.","journal-title":"Hum Reprod Update"},{"key":"1612_CR9","doi-asserted-by":"crossref","unstructured":"Albuquerque LET, Tso LO, Saconato H, Albuquerque MCRM, Macedo CR. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Cochrane Database Syst Rev. 2013;CD002808.","DOI":"10.1002\/14651858.CD002808.pub3"},{"key":"1612_CR10","doi-asserted-by":"crossref","unstructured":"Wang R, Lin S, Wang Y, Qian W, Zhou L. Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis. PLoS One. 2017;12(4):e0175985.","DOI":"10.1371\/journal.pone.0175985"},{"key":"1612_CR11","first-page":"82","volume":"4","author":"S Gordts","year":"2012","unstructured":"Gordts S, Van Turnhout C, Campo R, Puttemans P, Valkenburg M, Gordts S. A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF. Facts Views Vis ObGyn. 2012;4:82\u20137.","journal-title":"Facts Views Vis ObGyn"},{"key":"1612_CR12","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"1612_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","volume":"20","author":"HD Clark","year":"1999","unstructured":"Clark HD, Wells GA, Hu\u00ebt C, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 1999;20:448\u201352.","journal-title":"Control Clin Trials"},{"key":"1612_CR14","first-page":"241","volume":"35","author":"R Yang","year":"2015","unstructured":"Yang R, Luo L, Wang Y, et al. Clinical protocol selection in patients with polycystic ovary syndrome who undergone the first IVF\/ICSI-ET treatment. Reprod Contracept. 2015;35:241\u20136.","journal-title":"Reprod Contracept"},{"key":"1612_CR15","first-page":"455","volume":"23","author":"YQ Hu","year":"2014","unstructured":"Hu YQ, Cai JL, Liu LL, et al. Clinical outcomes of modified long protocol used in patients who failed in first cycle with antagonist protocol. Prog Obstet Gynecol. 2014;23:455\u20138.","journal-title":"Prog Obstet Gynecol"},{"key":"1612_CR16","first-page":"228","volume":"38","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Bao JH, Yao HR, et al. Clinical application and economic analysis of gonadotropin-releasing hormone antagonist protocol in patients with decreased ovarian reserve. Reprod Contracept. 2018;38:228\u201331.","journal-title":"Reprod Contracept"},{"key":"1612_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s12020-012-9706-z","volume":"42","author":"N Liu","year":"2012","unstructured":"Liu N, Ma Y, Li R, et al. Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols. Endocrine. 2012;42:708\u201316.","journal-title":"Endocrine"},{"key":"1612_CR18","first-page":"430","volume":"28","author":"J Zhao","year":"2017","unstructured":"Zhao J. Clinical application analysis of long acting follicular-phase GnRH agonist versus GnRH antagonist protocol in patients with polycystic ovary syndrome undergoing controlled ovarian stimulation. Chin J Woman Child Health Res. 2017;28:430\u20131.","journal-title":"Chin J Woman Child Health Res"},{"key":"1612_CR19","first-page":"13","volume":"50","author":"DF Xu","year":"2015","unstructured":"Xu DF, Wu QF. Application and effect of super long project and GnRH-antagnist in IVF-ET with the patients of PCOS. Jiangxi Med J. 2015;50:13\u20135.","journal-title":"Jiangxi Med J"},{"key":"1612_CR20","first-page":"94","volume":"23","author":"HL Xu","year":"2017","unstructured":"Xu HL, Zheng BH, Qiu SM, et al. Selection of controlled ovarian hyperstimualtion in patients with polycystic ovary syndrome who undergone in vitro fertilization. Strait J Prev Med. 2017;23:94\u20136.","journal-title":"Strait J Prev Med"},{"key":"1612_CR21","first-page":"818","volume":"37","author":"L Liu","year":"2015","unstructured":"Liu L, Zhao YQ, Liu P, et al. The clinical analysis of GnRH antagonist protocols on PCOS patients. Ningxia Med J. 2015;37:818\u201320.","journal-title":"Ningxia Med J"},{"key":"1612_CR22","first-page":"479","volume":"48","author":"LF Tian","year":"2013","unstructured":"Tian LF, Wu QF, Su Q, et al. A pregnancy outcomes comparison of low ovarian response in infertile patients undergoing different controlled ovarian hyperstimulation protocols in IVF treatment. Jianxi Med J. 2013;48:479\u201382.","journal-title":"Jianxi Med J"},{"key":"1612_CR23","first-page":"709","volume":"26","author":"ZM Zhao","year":"2018","unstructured":"Zhao ZM, Hao GM, Cui N, et al. Impact of long protocol in early follicular phase of patients with polycystic ovary syndrome who undergone in vitro fertilizaton-embryo transfer on clinical outcomes. Chin J Fam Plan. 2018;26:709\u201313.","journal-title":"Chin J Fam Plan"},{"key":"1612_CR24","doi-asserted-by":"crossref","unstructured":"Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev. 2000;(2):CD001299.","DOI":"10.1002\/14651858.CD001299"},{"key":"1612_CR25","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1210\/jc.2003-030805","volume":"88","author":"EM Kolibianakis","year":"2003","unstructured":"Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. J Clin Endocrinol Metab. 2003;88:5632\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1612_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000290062","volume":"70","author":"K-M Seow","year":"2010","unstructured":"Seow K-M, Lin Y-H, Hsieh B-C, et al. Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle. Gynecol Obstet Investig. 2010;70:64\u20138.","journal-title":"Gynecol Obstet Investig"},{"key":"1612_CR27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","volume":"80","author":"E Bosch","year":"2003","unstructured":"Bosch E, Valencia I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80:1444\u20139.","journal-title":"Fertil Steril"},{"key":"1612_CR28","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;CD001750.","DOI":"10.1002\/14651858.CD001750.pub3"},{"key":"1612_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.fertnstert.2014.03.047","volume":"101","author":"M Braakhekke","year":"2014","unstructured":"Braakhekke M, Kamphuis EI, Dancet EA, Mol F, van der Veen F, Mol BW. Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper. Fertil Steril. 2014;101:1203\u20134.","journal-title":"Fertil Steril"},{"key":"1612_CR30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1472-6483(10)61059-0","volume":"14","author":"HG Al-Inany","year":"2007","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14:640\u20139.","journal-title":"Reprod Biomed Online"},{"key":"1612_CR31","doi-asserted-by":"publisher","first-page":"e106854","DOI":"10.1371\/journal.pone.0106854","volume":"9","author":"J Xiao","year":"2014","unstructured":"Xiao J, Su C, Zeng X. Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis. PLoS One. 2014;9:e106854.","journal-title":"PLoS One"},{"key":"1612_CR32","doi-asserted-by":"crossref","unstructured":"Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4:CD001750.","DOI":"10.1002\/14651858.CD001750.pub4"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T03:30:01Z","timestamp":1620617401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01612-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"assertion":[{"value":"12 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}